Clinical trials
Cerebral Venous Thrombosis clinical trials
Below are recruiting cerebral venous thrombosis clinical trials, each written for real people, not researchers. We’re tracking 13 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07801638Recruiting
Anticoagulation plus tocilizumab for cerebral venous thrombosis
This trial tests a combination of blood thinners (anticoagulation) and a drug called tocilizumab, which targets inflammation, to treat acute cerebral venous thrombosis (a blood clot in a vein in the brain). It aims to see if this combined treatment improves recovery and reduces complications compared to blood thinners alone.
Beijing, Beijing MunicipalityAges 18–80 - NCT06551402RecruitingPhase 3
Dabigatran vs rivaroxaban for cerebral venous thrombosis
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
Kafr ash ShaykhAges 18–75 - NCT04660747Recruiting
Anticoagulant medication choices for cerebral venous thrombosis
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Amsterdam, North HollandAges 18 years+ - NCT05021198Recruiting
Study for people diagnosed with cerebral venous thrombosis
This study is for people who have been diagnosed with cerebral venous thrombosis (a blood clot in the brain’s venous system) at specific hospitals. It looks back at cases from 2014 to 2023 to learn from real-world patients.
LørenskogAges Any age - NCT07352358RecruitingPhase 4
Blood thinners plus batroxobin for brain vein clots
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
Beijing, Beijing MunicipalityAges 18–80 - NCT06947707Recruiting
Blood thinners for brain blood clot in Chinese patients
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Beijing, Beijing MunicipalityAges 18–80 - NCT07083609Recruiting
Blood-thinning pills for cerebral vein blood clots
This trial tests whether taking blood-thinning pills (called DOACs) after initial treatment can safely treat blood clots in the veins of the brain. You may be able to join if you recently had this condition and start the pills within the first two weeks of treatment.
Hanoi, HanoiAges 18 years+ - NCT03919305Recruiting
Study of blood clots in brain veins
This study follows people who have a blood clot in the brain’s venous drainage system. It aims to better understand this condition and may help improve how it is recognized and managed.
BeijingAges Any age - NCT05711173Recruiting
Study blood clot triggers and immune cell changes in clot patients
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
BordeauxAges 6–50 - NCT07515781Recruiting
VivaStent for Pulsatile Tinnitus Caused by Vein Narrowing
This study tests a stent (a small metal tube) placed in a narrowed vein in the brain to treat pulsatile tinnitus—a rhythmic ringing or whooshing sound in one ear that matches your heartbeat. The stent may improve blood flow and reduce or stop the sound.
ParisAges 18 years+ - NCT05041569Recruiting
MRI study of brain vein damage and swelling patterns
This pilot study uses an MRI scan that involves an injected contrast to look at how brain blood-flow pathways are being blocked or narrowed. The goal is to better understand the kind of damage caused by these vein problems, which may help doctors monitor and plan care.
Paris, ParisAges 18 years+ - NCT06347276Recruiting
PFO closure and brain microemboli study
This trial looks at whether closing a small hole in the heart (PFO) can reduce tiny clots traveling to the brain. It includes people who have had a stroke or migraine, and also those without symptoms but with high-risk features.
Beijing, Beijing MunicipalityAges 18–65 - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+
Hear when a new Cerebral Venous Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cerebral venous thrombosis?
- Yes. Clin2 currently lists 13 recruiting cerebral venous thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cerebral venous thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cerebral venous thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.